Abstract:Retinoic acid inducible-gene I (RIG-I) detects short dsRNA and stem-loop RNA species bearing a 5'-triphosphate end, and functions as one of the major sensors of RNA viruses (Myong, Cui et al., 2009, Pichlmair, Schulz et al., 2006). DDX58, which encodes the RIG-I protein has been newly identified as a susceptibility gene in psoriasis, a chronic inflammatory skin disorder affecting the skin in 1-3% of the general population (2009, Tsoi, Spain et al., 2012). Recently, interleukin (IL)-23 has been demonstrated as a key master cytokine that promotes T helper 17 (Th17) cell survival and proliferation, and targeting the IL-23p19 subunit with a monoclonal antibody results in the clinical improvement in psoriasis (Kopp, Riedl et al., 2015, Zheng, Danilenko et al., 2007). Yet what triggers IL-23 production in the skin of individuals genetically predisposed to develop psoriasis is still unclear. Here, we show that RIG-I expression is increased in the affected skin derived from psoriasis patients and from IL-23-induced mouse model of psoriasis. The activation of RIG-I by 5'ppp-dsRNA, its synthetic ligand, directly causes the production of IL-23 and promotes chronic cutaneous inflammation in mice that closely resembles human psoriasis. Repeated injections of IL-23 to the ears failed to induce IL-23 production and a full psoriasiform skin phenotype, both in germ-free and RIG-I knockout mice. Furthermore, RIG-I-mediated IL-23 production was confined to the CD11c+ myeloid dendritic cells (mDCs) via nuclear factor-kappa B (NF-κB) signaling, and stimulated RIG-I expression in an auto-regulatory feedback loop. Thus, our data suggest that the RIG-I-mediated antiviral response is pivotal for the local IL-23 production in the mDCs and for the IL-23-induced psoriasiform skin inflammation in mice, supporting the notion that dysregulation in the antiviral immune responses of hosts through the innate pattern-recognition receptors may trigger the skin inflammatory conditions in the pathophysiology of psoriasis.

Intracellular IL-1 Receptor Antagonist Isoform 1 Released from Keratinocytes upon Cell Death Acts as an Inhibitor for the Alarmin IL-1α

A Critical Role of the IL-1β-IL-1R Signaling Pathway in Skin Inflammation and Psoriasis Pathogenesis.

Psoriasis-like cutaneous inflammation in mice lacking interleukin-1 receptor antagonist

Caspase 1/11 Deficiency or Pharmacological Inhibition Mitigates Psoriasis-Like Phenotype in Mice

Alarmin Hnp-1 Promotes Pyroptosis And Il-1 Beta Release Through Different Roles Of Nlrp3 Inflammasome Via P2x7 In Lps-Primed Macrophages

UBE2L3 Reduces TRIM21 Expression and IL-1β Secretion in Epidermal Keratinocytes and Improves Psoriasis-Like Skin

IL-1 Signaling Regulates Skin Inflammation Through Directly Activating and Indirectly Chemoattracting Dermal Γδ T17 Cells (CAM1P.147)

Interleukin-38 overexpression in keratinocytes limits desquamation but does not affect the global severity of imiquimod-induced skin inflammation in mice

IL-17C Amplifies Epithelial Inflammation in Human Psoriasis and Atopic Eczema

IRAK2 Has a Critical Role in Promoting Feed-Forward Amplification of Epidermal Inflammatory Responses

A role for interleukin-1 in epidermal differentiation: regulation by expression of functional versus decoy receptors

IL-17 and IL-22 affected keratinocytes via IL-1β inducing NALP3-caspase-1 pathway (135.18)

Mast Cell Cytokines IL-1, IL-33, and IL-36 Mediate Skin Inflammation in Psoriasis: A Novel Therapeutic Approach with the Anti-Inflammatory Cytokines IL-37, IL-38, and IL-1Ra

IL-36 signaling in keratinocytes controls early IL-23 production in psoriasis-like dermatitis

Keratin 6, 16 and 17—Critical Barrier Alarmin Molecules in Skin Wounds and Psoriasis

Intrinsic Abnormalities of Keratinocytes Initiate Skin Inflammation Through the IL-23/T17 Axis in a MALT1-Dependent Manner.

Keratinocyte-derived IκBζ drives psoriasis and associated systemic inflammation

Plasmin Plays an Essential Role in Amplification of Psoriasiform Skin Inflammation in Mice (164.10)

The roles of interleukin-1 receptor accessory protein in certain inflammatory conditions

592 RIG-I Antiviral Signaling Drives Interleukin-23 Production and Psoriasis-Like Skin Disease

An Interleukin-25-Mediated Autoregulatory Circuit in Keratinocytes Plays a Pivotal Role in Psoriatic Skin Inflammation.